Newsletters
ANA Has Treated Over 100 Patients with New Alzheimer’s Disease Medication
This treatment, and these 100 people, represent a new era in Alzheimer’s treatments.
Denied Alzheimer’s Coverage: The Uphill Battle Against Insurance Companies
Some insurance companies may be discriminating against early stage Alzheimer’s patients.
Dr. Weisman and His Patients Featured in Article About MCI
In neurology we learn the same lessons again and again: Time is brain.
ANA Featured in Washington Post Article About Leqembi
Lecanemab has not been as widely tested in Black patients.
Dr. Weisman Quoted in Article about Quest Rapid Alzheimer’s Test
Almost anyone can take this quick test for Alzheimer’s without even going to the doctor. It’s a terrible idea.
An Open Letter to Highmark and Independence Blue Cross
Denial of coverage for lecanemab will have devastating consequences for millions of patients and families.